Support the expansion of Medicare's ability to negotiate the prices of more prescription drugs more quickly.

plans for expanding future drug price negotiations, including by enabling Medicare to negotiate the prices of more drugs more quickly

Cortez Masto announced a commitment to support expanded Medicare negotiation powers for more prescription drugs at a faster pace.

Cortez Masto, Wyden, Colleagues Announce Plans for Expanding Future Drug Price Negotiations, Denounce Trump’s Failure to Lower Cost of Prescription Drugs
primary · press_release · model gpt-4.1

“This commonsense fix builds on the legislation, passed and signed into law by Democrats, that caps insulin at $35 a month and allows Medicare to negotiate drug prices. We will continue to deliver real solutions that lower costs for American families and end Big Pharma’s price gouging.”

Cortez Masto introduced the SMART Prices Act and reiterated a commitment to lower prescription drug costs by expanding Medicare drug price negotiation, including negotiating more drugs sooner and increasing allowed discounts.

Cortez Masto, Klobuchar, Welch Push to Lower Prescription Drug Prices for Americans - Senator Catherine Cortez Masto
secondary · other · model gpt-5.5

Senators Catherine Cortez Masto, Ron Wyden, Peter Welch, and Ruben Gallego announced a Democratic plan for lowering prescription drug costs, including by enabling Medicare to negotiate the prices of more drugs more quickly.

Most recent direct statement located from Cortez Masto explicitly endorsing faster, broader Medicare drug-price negotiation.

partial same_term A for effort

Cortez Masto, Wyden, Colleagues Announce Plans for Expanding Future Drug Price Negotiations, Denounce Trump’s Failure to Lower Cost of Prescription Drugs
primary · model gpt-5.4-mini · confidence 95%

Cortez Masto, Klobuchar, and Welch introduced the SMART Prices Act, which would expand Medicare negotiation of drug prices, more than double the number of prescription drugs Medicare must negotiate to a minimum of 50 per year, and allow negotiation five years after FDA approval for the costliest drugs and biologics.

Concrete legislative action supporting the claim, but it is introduction rather than enacted policy.

partial same_term A for effort

Cortez Masto, Klobuchar, Welch Push to Lower Prescription Drug Prices for Americans - Senator Catherine Cortez Masto
secondary · model gpt-5.4-mini · confidence 93%

Cortez Masto's office said she and Democratic colleagues announced a plan that would enable Medicare to negotiate prices for more drugs more quickly.

Shows continued direct support for the promised policy expansion during her current Senate term, but the announcement is a plan rather than enacted law.

partial same_term A for effort

Cortez Masto, Wyden, Colleagues Announce Plans for Expanding Future Drug Price Negotiations, Denounce Trump’s Failure to Lower Cost of Prescription Drugs
primary · model gpt-5.5 · confidence 95%

Cortez Masto, Klobuchar, and Welch introduced the SMART Prices Act to more than double negotiated drugs to at least 50 per year and begin negotiations earlier.

Concrete legislative action aligns closely with the promise: more drugs and faster eligibility. The source does not show enactment.

partial same_term A for effort

Cortez Masto, Klobuchar, Welch Push to Lower Prescription Drug Prices for Americans - Senator Catherine Cortez Masto
secondary · model gpt-5.5 · confidence 94%

CMS listed 10 drugs for 2026, 15 drugs for 2027, and 15 drugs for 2028, with third-cycle negotiations occurring in 2026 for prices effective in 2028.

CMS implementation records show the negotiated-drug counts remained on the IRA schedule, not expanded to 50 per year or accelerated as promised.

never same_term

Selected Drugs and Negotiated Prices
secondary · model gpt-5.5 · confidence 92%

The statute set Medicare negotiation at 10 drugs for 2026, 15 for 2027, 15 for 2028, and 20 for 2029 or later years.

The baseline law created negotiation authority but did not include the later promised expansion to more drugs more quickly.

never same_term

Public Law 117-169, Inflation Reduction Act of 2022
secondary · model gpt-5.5 · confidence 90%

The 2025 reconciliation law expanded and clarified the orphan-drug exclusion under the Medicare Drug Price Negotiation Program, effective for price applicability years beginning in 2028.

Rather than enacting Cortez Masto's expansion, the enacted 2025 law narrowed negotiation eligibility for some drugs, supporting non-fulfillment.

never same_term

Public Law 119-21, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14
secondary · model gpt-5.5 · confidence 88%

Cortez Masto, Welch, and Wyden introduced the No Big Blockbuster Bailouts Act to repeal certain negotiation exemptions and make high-spending orphan-status drugs eligible.

Shows additional concrete legislative effort to protect or broaden Medicare negotiation eligibility after the 2025 law, but not enactment.

partial same_term A for effort

Cortez Masto, Welch, Wyden Fight to Protect Seniors from Republicans’ Big Pharma Bailout, Ensure Access to Life-Saving Prescription Drugs
secondary · model gpt-5.5 · confidence 90%